Wednesday, July 8, 2026

Drug profile · INN

oxycodone

oxycodone (ENDONE) is a mu opioid receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

FDA: approved TGA: approved NMPA: clinical trials
US status approved
Patents linked 9
Pipeline programs 20
News articles 2
Drug details — oxycodone

Quick answer

oxycodone (ENDONE) is a mu opioid receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN oxycodone
Brand ENDONE
Mechanism Mu opioid receptor agonist
Target Mu-type opioid receptor
Route ORAL
Formulation CAPSULE, EXTENDED RELEASE

Mechanism of action

Mu opioid receptor agonist

Primary target: Mu-type opioid receptor

Approval history

Authority Status Date
FDA approved
TGA approved
NMPA clinical trials

Recent coverage

Pipeline programs

  1. Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone Phase 3 · Teva Pharma · Chronic Pain
  2. Oxycodone DETERx Phase 3 · COLLEGIUM PHARMACEUTICAL · Chronic Low Back Pain
  3. Oxycodone Naltrexone (a) Phase 3 · ELITE PHARMACEUTICALS INC · Pain
  4. Oxycodone/Naltrexone Capsules Phase 3 · ELITE PHARMACEUTICALS INC · Withdrawal Symptoms
  5. oxycodone 15 mg Phase 2 · BRIGHT MINDS BIOSCIENCES · Opioid-Related Disorders
  6. Endo Tool Phase 1 · United Therapeutics Europe · Burns
  7. OxyCODONE 5 mg Oral Tablet Phase 1 · BRIGHT MINDS BIOSCIENCES · Pain
  8. Oxycodone Phase 1 · BRIGHT MINDS BIOSCIENCES · Opioid Use Disorder

Related & competitor drugs

  1. alvimopan Mu opioid receptor antagonist
  2. loperamide hydrochloride Mu opioid receptor agonist
  3. methadone hydrochloride Mu opioid receptor agonist
  4. morphine sulfate Mu opioid receptor agonist
  5. oxycodone hydrochloride Mu opioid receptor agonist
  6. propoxyphene hydrochloride Mu opioid receptor agonist
  1. US 10668060

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 10646485

    Process of making stable abuse-deterrent oral formulations

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 10188644

    Process of making stable abuse-deterrent oral formulations

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 10004729

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 9968598

    Process of making stable abuse-deterrent oral formulations

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 9737530

    Process of making stable abuse-deterrent oral formulations

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 9682075

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 9682988

    Solid salt form of α-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7771707

    Abuse-deterrent drug formulations

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is oxycodone?

oxycodone (ENDONE) is a mu opioid receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for oxycodone?

ENDONE is a marketed brand name for oxycodone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of oxycodone?

oxycodone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.